Sen. Cassidy Suggests Importing Generics From EU To Pressure US Prices
Executive Summary
Idea may require tweaking existing agreements between FDA and EMA, but is another twist on drug importation, a concept that FDA opposes.
You may also be interested in...
Democrats’ Drug Pricing Bills Echo Trump Ideas But Broad Republican Support Unlikely
Upcoming House Oversight Committee hearing on drug pricing offers a chance for fireworks, but broader prospects for new Democratic pricing legislation seem limited.
Gottlieb: Real Risk Of Congressional Action If Anti-Competitive Actions Continue
To remain shielded from political forces that could change incentives, pharmaceutical industry must adopt 'a certain set of values,' US FDA Commissioner says.
Brand 'Evergreening' Piques FDA Interest, But Solutions Remain Elusive
Agency eager to hear suggestions on the subject, also known as product hopping, but even reform advocates were cautious of stifling meaningful reformulations of products.